Capital Advisors Ltd’s Omnicell OMCL Stock Holding History

Capital Advisors Ltd’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5	Closed	–	–	1518
2022 Q3	$0	Buy	+5	New	+$525	﹤0.01%	1438

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Capital Advisors Ltd's OMCL Position: Q4 2022 in Review

Capital Advisors Ltd sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 5 shares.

Capital Advisors Ltd first reported a position in OMCL in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

Capital Advisors Ltd reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
Capital Advisors Ltd sold 5 Omnicell shares in Q4 2022.
Capital Advisors Ltd first reported a position in Omnicell in Q3 2022 and held it in 1 quarter.
Capital Advisors Ltd's Omnicell position peaked at $0 in Q3 2022.
329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Capital Advisors Ltd's 13F filing for Q4 2022, filed 7 Feb 2023.